摘要 ：统计22家国内上市仪器公司2025年业绩预告数据，拆解各企业业绩变动核心原因，剖析行业发展现状与趋势，为 市场参与者提供参考。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 2026 年初以来，国内仪器行业上市企业陆续披露 2025 年业绩预告，行业整体经营态势逐步清晰。本文对 统计到的 22 家国产仪器厂商业绩预告进行系统梳理，涵盖多个细分领域， 为市场参与者提供参考。 从净利润来看， 共有11家企业盈利，11家企业亏损；与上年同期相比，盈利企业中8家实现同比增长，3家 盈利但增速平缓或略有波动，亏损企业中4家实现亏损收窄，7家出现亏损扩大或由盈转亏。 可以看出，在 国内下游需求波动、行业竞争持续加剧、政策环境调整及全球供应链不稳定的多重背景下，国产仪器行业业 绩分化态势进一步加剧，部分企业凭借前瞻性的战略布局实现增长，展现出强劲的经营韧性，而部分企业则 受困于业务转型、资产减值等因素，面临阶段性经营压力。 埃 科 光 电 | | | 2025年度国产仪器上市企业净利润统计表 | | | | --- | --- | --- | ...

2月6日，聚光科技涨5.12%，截至发稿，报16.02元/股，成交9940.19万元，换手率1.42%，总市值71.89 亿元。 资料显示，聚光科技(杭州)股份有限公司位于浙江省杭州市滨江区阡陌路459号，成立日期2002年1月4 日，上市日期2011年4月15日，公司主营业务涉及研发、生产和销售应用于环境监测、工业过程分析、 实验室仪器等领域的仪器仪表。主营业务收入构成为：仪器、相关软件及耗材69.24%，运营服务、检 测服务及咨询服务16.42%，环境设备及工程10.46%，其他3.87%。 从聚光科技十大流通股东角度 数据显示，睿远基金旗下1只基金位居聚光科技十大流通股东。睿远成长价值混合A（007119）三季度 增持242.09万股，持有股数1085.88万股，占流通股的比例为2.42%。根据测算，今日浮盈赚取约846.99 万元。 睿远成长价值混合A（007119）基金经理为傅鹏博、朱璘。 截至发稿，傅鹏博累计任职时间17年25天，现任基金资产总规模210.87亿元，任职期间最佳基金回报 429.69%， 任职期间最差基金回报-3.8%。 朱璘累计任职时间6年320天，现任基金资产总规模210.87 ...

Investment Rating - The investment rating for the healthcare industry is "Positive" and maintained [14] Core Insights - The funding levels for Chinese innovative pharmaceutical companies are increasing, leading to a gradual improvement in the research and development (R&D) investment sentiment within the industry. This is expected to usher in a new cycle of prosperity for the innovative drug industry chain [5][12] - The trend of external business development (BD) is likely to benefit the domestic early-stage research industry significantly, as new business models allow early-stage projects to become tradable and monetizable assets, enhancing R&D investment returns [13] Summary by Sections Innovative Chain Development Review - Before 2020, multiple factors converged to initiate a significant rise in China's innovative drug sector, leading to the rapid development of the innovative chain, including CXO and life sciences services [10][30] - From 2020 to the first half of 2022, the global public health crisis accelerated capital inflow into the biopharmaceutical sector, resulting in high demand and a leap in the innovative chain segment, which also triggered a wave of IPOs and substantial supply-side expansion [10][39] - The second half of 2022 to 2024 saw a transition from a heated to a cooling phase, with a significant shift in supply-demand dynamics leading to industry internal competition and pressure on revenues and profit margins [10][54][57] Improvement in R&D Investment Sentiment - Starting from 2025, the R&D investment sentiment in China's innovative drug sector is expected to improve, with companies experiencing increased funding levels. The total amount raised through IPOs and additional offerings in 2025 is projected to reach 201.5 billion yuan, a 145% year-on-year increase [11][62] - The potential milestone payments from external BD are expected to reach 880.5 billion yuan in 2025, marking a 185.9% year-on-year increase, indicating a robust funding environment for innovative drug companies [11] Benefits to Early-stage Research Industry - The new external BD business model enhances the R&D investment return rates for Chinese innovative drug companies, thereby increasing their willingness to invest in R&D [11][13] - The early-stage research industry, including drug discovery CROs and clinical trial services, is expected to benefit significantly from the external BD trend, with leading companies in these segments poised for rapid growth [13]

证券代码：300203 证券简称：聚光科技 公告编号：2026-004 聚光科技（杭州）股份有限公司 关于回购公司股份的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 聚光科技(杭州)股份有限公司(下称"公司")于2025年8月20日召开第五届 董事会第二次会议，审议通过了《关于回购公司股份方案的议案》。同意公司使 用自有资金和自筹资金，以集中竞价交易方式回购部分公司已在境内发行的人民 币普通股（A股）股票，并在未来适宜时机用于实施股权激励计划或员工持股计 划。本次回购资金总额不低于人民币10,000万元（含本数）且不超过人民币15,000 万元（含本数），回购价格不超过人民币29.50元/股（含），回购期限为自公司 董事会审议通过本次回购方案之日起12个月内。具体内容详见公司于2025年8月 20日、2025年8月27日分别在巨潮资讯网披露的《关于回购公司股份方案的公告》 （公告编号：2025-031）、《回购报告书》（公告编号：2025-037）。 公司已取得交通银行股份有限公司杭州浣纱支行出具的《交通银行股票回购 增持贷款承诺函》，承诺为公司提 ...

截至9月30日，聚光科技股东户数2.30万，较上期增加13.30%；人均流通股19483股，较上期减少 11.74%。2025年1月-9月，聚光科技实现营业收入20.50亿元，同比减少11.10%；归母净利润-6233.51万 元，同比减少152.98%。 分红方面，聚光科技A股上市后累计派现6.30亿元。近三年，累计派现1.12亿元。 机构持仓方面，截止2025年9月30日，聚光科技十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股1381.53万股，相比上期减少518.92万股。睿远成长价值混合A（007119）位居第五大流通 股东，持股1085.88万股，相比上期增加242.09万股。诺安先锋混合A（320003）、汇添富医药保健混合 （470006）退出十大流通股东之列。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 责任编辑：小浪快报 1月30日，聚光科技跌1.78%，成交额1.67亿元。两融数据显示，当日聚光 ...

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 近期，聚光科技发布2025年业绩预告： 1、业绩预告期间：2 0 2 5年1月1日至2 0 2 5年1 2月3 1日。 2、业绩预告情况：预计净利润为负值 2 0 0 0万元左右；预计PPP等项目减值损失金额较去年同期有所减少。最终 计提减值金额将由公 司聘请的专业评估机构及审计机构进行评估和审计后确定。报告期公 司实现的经营活动产生的 现金流量净额约3 . 7亿元。 一、本期业绩预计情况 | 项目 | | 本报告期 | | 上年同期 | | --- | --- | --- | --- | --- | | 归属于上市公司股东的净利润 | -24, 000 | | -19,000 | 20, 686. 18 | | 扣除非经常性损益后的净利润 | -28, 500 | | -23,500 | 12,743.5 | 注 ： 上表中的 " 万 元 " 均 指 人 民 币 万 元 。 二、与会计师事务所沟通情况 本次业绩预告未经会计师事务所审计。但公司已就业绩预告有关事项与会计师事务所 进行了预 沟 ...

Market Overview - On January 30, the environmental equipment sector rose by 0.09% compared to the previous trading day, with Hengyu Environmental leading the gains [1] - The Shanghai Composite Index closed at 4117.95, down 0.96%, while the Shenzhen Component Index closed at 14205.89, down 0.66% [1] Stock Performance - Hengying Environmental (688309) closed at 31.60, up 12.06% with a trading volume of 58,100 shares and a transaction value of 175 million yuan [1] - Other notable performers included Meiyu Technology (688376) with a closing price of 69.02, up 2.77%, and Lihua Technology (300800) at 12.69, up 2.59% [1] - The table of stock performance shows various companies in the environmental equipment sector with their respective closing prices, percentage changes, trading volumes, and transaction values [1] Capital Flow - The environmental equipment sector experienced a net outflow of 124 million yuan from institutional investors, while retail investors saw a net inflow of 151 million yuan [2] - The capital flow table indicates the net inflow and outflow for various stocks within the sector, highlighting the dynamics between institutional and retail investors [2][3] Individual Stock Analysis - Yinfeng Environment (000967) had a net inflow of 28.08 million yuan from institutional investors, while Hengying Environmental (688309) saw a net inflow of 18.60 million yuan [3] - Conversely, Huahong Technology (002645) faced a significant decline of 10.00%, with a trading volume of 323,900 shares and a transaction value of 507 million yuan [2][3]

智通财经APP讯，聚光科技(300203.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净亏损 1.9亿元至2.4亿元;扣除非经常性损益后的净亏损2.35亿元至2.85亿元。 ...

证券代码：300203 证券简称：聚光科技 公告编号：2026-003 聚光科技（杭州）股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或 重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2、业绩预告情况：预计净利润为负值 单位：万元 | 项 目 | | 本报告期 | | 上年同期 | | --- | --- | --- | --- | --- | | 归属于上市公司股东的净利润 | -24,000 | ～ | -19,000 | 20,686.18 | | 扣除非经常性损益后的净利润 | -28,500 | ～ | -23,500 | 12,743.5 | 注：上表中的"万元"均指人民币万元。 二、与会计师事务所沟通情况 本次业绩预告未经会计师事务所审计。但公司已就业绩预告有关事项与会计师事务所 进行了预沟通，公司与会计师事务所在本报告期的业绩预告方面不存在重大分歧。 三、业绩变动原因说明 为应对客观环境的变化，2025 年公司坚定推进以打造精品战略为核心的高质量转 ...

Investment Rating - The report maintains a "Buy" rating for key companies in the environmental monitoring sector, such as Huicheng Environmental and GaoNeng Environment [6][22]. Core Insights - The report highlights the dual drivers of policy and demand in the environmental monitoring sector, indicating that leading companies will continue to benefit from recent regulatory changes [1][12]. - Recent government guidelines signal a shift in soil remediation practices, creating multiple growth opportunities in soil remediation and environmental consulting sectors [1][12]. - The report emphasizes the importance of high dividend assets and growth-oriented companies in the current low macroeconomic interest rate environment [2][22]. Summary by Sections Investment Views - The report discusses the release of guidelines by three departments to enhance the connection between pollution site remediation and development, marking a transition in soil remediation practices [9][12]. - It also covers the introduction of differentiated management for air quality performance in key industries, which provides incentives for companies to transition towards greener practices [13][20]. - The report notes that institutional holdings and valuations in the environmental sector are at historical lows, suggesting a potential for sustained rebounds [22]. Market Performance - The environmental sector outperformed the broader market, with a reported increase of 4.72% compared to the Shanghai Composite Index's 0.84% increase [24]. - Sub-sectors such as monitoring (5.55%), energy saving (7.99%), and solid waste (5.67%) showed significant gains, indicating strong market interest [24]. Industry News - The report mentions the release of the 2026 version of hazardous waste management guidelines, aimed at improving the classification and management of solid waste [35]. - It also highlights the recognition of zero-carbon factories in Henan Province, showcasing advancements in energy efficiency and environmental standards [36]. Key Announcements - The report includes performance forecasts for various companies, indicating significant expected growth for Huicheng Environmental and GaoNeng Environment due to their strong project pipelines and technological advancements [22][23].